Identification and Management of Obese Patients in a Pediatric Orthopaedic Clinic

Natalia Davila1, Joy Vess, Emily E Johnson

  • 1Natalia Davila, DNP, MSN, MA, CPNP, Pediatric Orthopaedics, Medical University of South Carolina; College of Nursing, Medical University of South Carolina, Charleston. Joy Vess, DNP, ACNP, Instructor, Medical University of South Carolina, Charleston. Emily E. Johnson, PhD, Assistant Professor, Medical University of South Carolina, Charleston.

Orthopedic Nursing
|May 25, 2017
PubMed

Insights

A quality improvement project successfully increased childhood obesity identification and referrals to weight management programs in a pediatric orthopaedic clinic. Provider education significantly boosted obesity diagnosis rates and program referrals.

Area of Science:

  • Pediatric healthcare quality improvement
  • Public health and obesity management
  • Orthopaedic patient care

Background:

  • Childhood obesity is a significant health issue impacting bone formation and overall well-being.
  • Current guidelines recommend early identification of obesity risk factors like elevated BMI, diet, and physical activity.
  • Pediatric orthopaedic clinics often underdiagnose obesity and have inconsistent weight management referrals.

Purpose of the Study:

  • To enhance the identification of obese children within a pediatric orthopaedic setting.
  • To increase the number of referrals to established weight management programs.

Main Methods:

  • A quality improvement initiative was implemented in a pediatric orthopaedic clinic.
  • Provider education focused on obesity management guidelines and referral pathways.
  • Data collection involved electronic medical record review of obesity diagnosis and referrals.

Main Results:

  • Documented obesity diagnoses rose from 11% to 53% post-intervention.
  • Referrals to the Heart Healthy weight management program saw a 400% increase.
  • The intervention demonstrated significant improvements in patient identification and care coordination.

Conclusions:

  • Educational interventions effectively improve obesity diagnosis rates in pediatric orthopaedic settings.
  • Targeted education can significantly increase referrals to weight management programs.
  • This approach enhances comprehensive care for obese children within specialized clinics.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250